Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 3 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Validity and utility of HER2/ERBB2 copy number variation assessed in liquid biopsies from breast cancer patients: A systematic review.
Cancer Treat Rev. 2022 May;106:102384. doi: 10.1016/j.ctrv.2022.102384. Epub 2022 Mar 29.
Cancer Treat Rev. 2022.
PMID: 35366566
Free article.
Review.
Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer.
Verschoor N, Smid M, Jager A, Sleijfer S, Wilting SM, Martens JWM.
Verschoor N, et al.
Breast Cancer Res. 2023 Nov 15;25(1):145. doi: 10.1186/s13058-023-01743-z.
Breast Cancer Res. 2023.
PMID: 37968696
Free PMC article.
Item in Clipboard
Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients.
Isebia KT, Dathathri E, Verschoor N, Nanou A, De Jong AC, Coumans FAW, Terstappen LWMM, Kraan J, Martens JWM, Bansal R, Lolkema MP.
Isebia KT, et al. Among authors: verschoor n.
Cancers (Basel). 2022 Sep 10;14(18):4404. doi: 10.3390/cancers14184404.
Cancers (Basel). 2022.
PMID: 36139564
Free PMC article.
Item in Clipboard
Bladder-sparing (chemo)radiotherapy in elderly patients with muscle-invasive bladder cancer: a retrospective cohort study.
Verschoor N, Heemsbergen WD, Boormans JL, Franckena M.
Verschoor N, et al.
Acta Oncol. 2022 Aug;61(8):1019-1025. doi: 10.1080/0284186X.2022.2101381. Epub 2022 Jul 26.
Acta Oncol. 2022.
PMID: 35880448
Item in Clipboard
Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival.
Verschoor N, de Weerd V, Van MN, Kraan J, Smid M, Heijns JB, Drooger JC, Zuetenhorst JM, van der Padt-Pruijsten A, Jager A, Sleijfer S, Martens JWM, Wilting SM.
Verschoor N, et al.
NPJ Breast Cancer. 2023 Jul 14;9(1):61. doi: 10.1038/s41523-023-00563-w.
NPJ Breast Cancer. 2023.
PMID: 37452019
Free PMC article.
Item in Clipboard
Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial.
Verschoor N, Bos MK, de Kruijff IE, Van MN, Kraan J, Drooger JC, Zuetenhorst JM, Wilting SM, Sleijfer S, Jager A, Martens JWM.
Verschoor N, et al.
Breast Cancer Res Treat. 2024 May;205(1):87-95. doi: 10.1007/s10549-023-07231-4. Epub 2024 Jan 31.
Breast Cancer Res Treat. 2024.
PMID: 38291268
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite